Loading...
•
Dec 31, 2023
Puma Biotechnology Q4 2023 Earnings Report
Puma Biotechnology reported positive net income for Q4 2023, with total revenue of $72.2 million, including $53.2 million in product revenue and $19.0 million in royalty revenue.
Key Takeaways
Puma Biotechnology reported a net income of $12.3 million for the fourth quarter of 2023, compared to a net loss of $5.6 million for the same period in 2022. Total revenue for the quarter was $72.2 million, with product revenue contributing $53.2 million and royalty revenue $19.0 million.
Puma Biotechnology reported positive net income for both the fourth quarter and full year 2023.
Q4 2023 net income was $12.3 million, or $0.26 per basic and diluted share, compared to a net loss of $5.6 million, or $0.12 per basic and diluted share, for Q4 2022.
Total revenue for Q4 2023 was $72.2 million, which includes $53.2 million from product revenue and $19.0 million from royalty revenue.
The company is advancing the clinical development of alisertib, with the initiation of a Phase II clinical trial (ALISCA-Lung1) in February for extensive stage small cell lung cancer.
Revenue by Segment
Forward Guidance
Puma Biotechnology provided financial outlook for the first quarter and full year 2024.
Positive Outlook
- Net Product Revenue for Q1 2024 is expected to be $38 - $40 million.
- Net Product Revenue for FY 2024 is expected to be $183 - $190 million.
- Royalty Revenue for Q1 2024 is expected to be $2.5 - $3 million.
- Royalty Revenue for FY 2024 is expected to be $30 - $33 million.
- Net Income for FY 2024 is expected to be $12 - $15 million.
Challenges Ahead
- Net Income/(Loss) for Q1 2024 is expected to be $(10) - $(12) million.
- Gross to Net Adjustment for Q1 2024 is expected to be 23% - 24%.
- Gross to Net Adjustment for FY 2024 is expected to be 21.5% - 22.5%.
- License Revenue for Q1 2024 is expected to be $0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...